Advertisement

NanoViricides Inc., a biotechnology firm in West Haven, Conn., has taken in $5 million through a stock offering under a shelf registration with Seaside 88 LP.

The drug maker, which focuses on antiviral therapy, filed documents back in March 2010 to raise up to $40 million through the occasional sale of company stock.  Since then, it has raised $5 million in another placement under the shelf registration, also with Seaside 88, in May 2010,  and another $2.5 million in December.

SOURCE

Advertisement
Advertisement